Rating: Sell — Conviction: Low
LSB's 2026 earnings rest on war-driven nitrogen prices: Q2 Tampa ammonia averaged $787/t against $416/t a year earlier. The price is already rolling over, with Tampa down four straight months to $555 in September. Once realized prices return to FY2025 levels, sustaining capex plus recurring turnarounds leave thin free cash flow. Both valuation methods then sit below today's price. Only a multi-year extension of the Middle East supply loss justifies the stock.
Conviction tests (3a-v-c): T1 fail (Sell → Hold at −1pp: base −13.5%; −32.1% at +1pp) · T2 pass (Gordon $6.74 −32%, exit $8.29 −16%) · T3 pass · T4 pass
Business overview
LSB makes nitrogen chemicals at three US plants: El Dorado (AR), Cherokee (AL) and Pryor (OK). In FY2025 it sold 1.51mm short tons. AN & nitric acid (641k t) made up 39% of sales, UAN (550k t) 31%, ammonia (316k t) 24%, and other products 6% (FY2025 release; 10-K). AN and nitric acid go mainly to industrial and mining buyers; UAN and much of the ammonia go to agriculture at spot-linked prices. Five customers took ~32% of FY2025 sales (10-K). Three variables drive earnings: realized nitrogen prices, which follow Tampa ammonia and NOLA UAN; US natural gas cost ($2.96/MMBtu in Q2 2026 vs $3.50 a year earlier); and plant reliability. Turnaround costs are excluded from Adjusted EBITDA.
Competition
The listed comparables that matter are CF Industries (CF), the dominant North American ammonia/UAN producer; CVR Partners (UAN), a UAN pure play; and Nutrien (NTR). All three sell into the same Gulf-import-parity prices. Pressure shows up in price, not share. Tampa ammonia peaked at $825/t in May 2026 and fell to $555 in September (Fertilizer Daily, 2026-09-10). The causes: China released urea export quotas in June, Iran and Oman agreed a Hormuz safe-shipping framework, and Trinidad raised utilization. September is still ~15% above the early-2026 baseline of ~$480. On one TTM definition (StockAnalysis, 2026-10-02), CF trades at 4.79x EV/EBITDA, UAN at 6.32x and NTR at 8.01x, against 6.52x for LXU. All sit on war-elevated trailing earnings. Current US import trade measures were not checked; the thesis does not rely on them.
Bull case
- Disruption persists — the Middle East war (now in its eighth month per the macro log) keeps Gulf ammonia and urea exports impaired, so realized prices hold near the 2026 run rate (~$440–455/t vs $408 in FY2025) through 2030. Plays out if the Hormuz framework fails and Chinese export quotas tighten again. Model: realized_price
- Reliability finally sticks — El Dorado has run above nameplate since its Q2 turnaround (~1,375 t/day, its best since 2016). With no major turnaround in 2027, volumes recover ~6%. Plays out if FY2027 production guidance comes in above FY2025's 1.51mm t sold. Model: volume_growth
- Low-carbon premium — the El Dorado CCS project (Q1 2027, subject to an EPA Class VI permit) captures 400–500k t of CO₂ a year. It is guided to add $25–30mm of annual earnings over a 12-year credit period, and could earn a premium multiple. Plays out if the permit arrives on time and 45Q credits survive. Model: fixed_costs, exit_ev_ebitda
Bear case
- Prices normalize — Hormuz flows resume and Chinese urea returns, so realized prices fall back to FY2024 levels (~$375–385/t). Plays out if Tampa settles below $500 into the 2027 spring season. Model: realized_price, exit_ev_ebitda
- Turnarounds and capex eat the cash — LSB has a history of unplanned outages, and its turnaround costs ($28.8mm in Q2 2026 alone) sit outside Adjusted EBITDA. Sustaining capex plus turnarounds roughly equal D&A (~$85mm). At mid-cycle prices, base free cash flow is only ~$50–60mm a year. Plays out if 2027–28 capex stays near the FY2024–25 level of $77–92mm. Model: capex_pct_rev, volume_growth
- CCS slips — no Class VI permit, so the $25–30mm/yr never arrives while ~$45mm (est.) is spent on it in 2026. Plays out if the permit is still pending at the Q4 2026 call. Model: fixed_costs
Valuation & balance sheet
| Metric (definition) | Current | Own history (range or 5y avg) | Peers | Source, as-of |
|---|---|---|---|---|
| EV/EBITDA, model basis (mkt cap − cash & ST inv. + debt; Adj. EBITDA, no leases) | 5.78x FY2025 · 4.68x LTM | FY2021–25 Adj. EBITDA $129.5–414.7mm | n/a on this basis | Model; FY2025 & Q2 2026 releases |
| EV/EBITDA, TTM (aggregator definition) | 6.52x | n/a (unverified) | CF 4.79x · UAN 6.32x · NTR 8.01x | StockAnalysis, 2026-10-02 |
| Forward P/E (aggregator consensus) | 9.36x | n/a | CF 9.04x · NTR 14.19x · UAN n/a (8.23x trailing) | StockAnalysis, 2026-10-02 |
| P/B (aggregator) | 1.32x | n/a | CF 3.03x · UAN 3.80x · NTR 1.29x | StockAnalysis, 2026-10-02 |
Model-implied value range (from model-summary.json; energy module, Gordon-growth DCF and exit-EV/EBITDA DCF, midpoints): Bear $1.11 · Base $7.52 · Bull $23.34 per share, i.e. implied returns of −88.7% / −23.7% / +136.7% vs $9.86. These ranges show how the bull and bear drivers translate into value; they are not price targets. The price sits ~15% of the way from base to bull, so the market is paying for only modest persistence of 2026 pricing. Re-rating. The two base methods differ by more than 10%. The exit method ($8.29) uses 6.0x Y5 EBITDA. That is a 4% re-rating against today's 5.78x on FY2025 and 28% against 4.68x on LTM. The Gordon method ($6.74), at an 8.6% WACC and 1% growth, embeds a lower terminal multiple; the gap is the exit method's higher one. No tail sensitivity was run: no customer is ≥50% of sales, and the bear case is already near zero.
Balance sheet: net leverage 1.38x FY2025 EBITDA (model), ~1.1x LTM. Coverage is 5.9x on the 6.25% coupon. Liquidity is $218.0mm of cash and short-term investments (2026-06-30). The nearest material maturity is $438.6mm of 6.25% senior secured notes due October 2028, the whole debt stack. Ratings: n/a (unverified).
Model note: Built and LibreOffice-verified (3,511 formula cells match). EBITDA is company Adjusted EBITDA, which adds back turnaround expense. Turnarounds are treated as a recurring cash cost inside capex: ~$40mm (est.) in 2026 and ~$15mm/yr after. The variable/fixed cost split (unit cash cost ~$140/t, fixed ~$244mm) is my estimate, calibrated to FY2025 cash costs; it is not a disclosed line. Volume history before FY2025 is blank because consistent product tonnage was not retrieved. 2026 capex (~$80mm core per call summaries; CCS ~$45mm est. vs $10.8mm H1 actual) is partly unverified. Unverified inputs: none flagged est. Assumptions without basis: none. Scenario consistency: all OK. No EPS guidance; base 2026 EPS ($1.01) is within 5% of the ~$1.05 implied by the 9.36x forward P/E. WACC 8.6% uses a judgment beta of 1.2 vs a reported 0.31; at ~6% WACC the base would sit near the price, which with T1 is why conviction is Low.
Scenario stress test
Reasoned from the bull/bear drivers above. The model column comes from the scenario overlays (Base case + shock).
| Scenario | Effect | Mechanism | Magnitude | Model Δ value vs Base ($/sh) |
|---|---|---|---|---|
| S1 Fast equity crash | − | Small-cap de-rating; fertilizer demand unaffected over weeks | Low | −$0.93 |
| S2 Slow bear / recession | − | Industrial and mining AN/nitric acid volumes fall and nitrogen prices soften; corn demand cushions part | High | −$4.90 |
| S3 Rapid rate shock | − | Higher discount rate on a levered equity; notes fixed to 2028 | Low | −$0.82 |
| S4 Slow rate grind | − | 2028 notes refinance at higher coupons; input-cost and gas inflation | Med | −$1.82 |
| S5 Soft-landing cuts | + | Steady industrial demand, lower discount rate | Med | +$1.28 |
| S6 Recession-driven cuts | − | Recessionary volume and price drop outweighs lower rates | High | −$4.01 |
| S7a Credit liquidity shock | − | HY spreads gap; secured high-yield issuer de-rates | Low | −$0.93 |
| S7b Slow default cycle | − | 2028 maturity refinances into a wider-spread market | Low | −$0.62 |
| S8 Stagflation | + | Nitrogen reprices with energy and grain faster than US gas; partly offset by input-cost inflation | Med | +$1.24 |
| S9a Dollar spike | − | Strong dollar cheapens imported nitrogen into the US Gulf | Low | −$0.57 |
| S9b Dollar slide | + | Weak dollar lifts import-parity pricing | Low | +$0.57 |
| S10 Melt-up | 0 | No material effect, not modeled | Low | +$0.00 |
| S11 Energy supply shock | + | Middle East ammonia/urea supply lost; global nitrogen priced off EU gas while US gas stays cheap. Two-year shock, so it doesn't reach the price | Med | +$1.71 |
| S12 Mega-cap/AI derating | 0 | No material effect, not modeled | Low | +$0.00 |
Currently active/on watch per the playbook: S3 partially active; S8, S10, S11 on watch (state.md). S11 is the live driver of 2026 nitrogen prices.
What would change the call
Upgrades if: Tampa ammonia re-firms above ~$650/t into the 2027 spring season and Q3/Q4 2026 realized prices hold at or above ~$440/t; or the CCS permit lands and FY2027 guidance shows volumes above 1.55mm t, with capex plus turnarounds below ~$85mm. Downgrades if: n/a for a Sell. Conviction rises if Tampa settles below $500 for Q4 2026 while the 2026 capex and turnaround bill comes in above ~$160mm.
Watch items
- W1: Q3 2026 net sales per ton sold and Adjusted EBITDA — ≥$440/t supports bull 1; ≤$400/t confirms the base path — Q3 8-K release — ~late Oct 2026 — Model: realized_price
- W2: Monthly Tampa ammonia settlements — below $500/t by the Jan 2027 settlement confirms bear 1; above $650/t supports bull 1 — trade press — monthly — Model: realized_price
- W3: EPA Class VI permit and CCS start-up at El Dorado — permit granted and operations by Q1 2027 vs further slippage — 8-K / Q4 2026 release — Q1 2027 — Model: fixed_costs
- W4: FY2027 volume and capex guidance — sales volumes vs 1.55mm t, capex plus turnaround vs ~$85mm — Q4 2026 release — ~Feb 2027 — Model: volume_growth, capex_pct_rev
Sources
- SEC EDGAR XBRL companyconcept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, CIK 60714 — https://data.sec.gov/api/xbrl/companyconcept/CIK0000060714/us-gaap/RevenueFromContractWithCustomerExcludingAssessedTax.json — accessed 2026-10-04
- SEC EDGAR XBRL companyconcept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, CIK 60714 — https://data.sec.gov/api/xbrl/companyconcept/CIK0000060714/us-gaap/PaymentsToAcquirePropertyPlantAndEquipment.json — accessed 2026-10-04
- LSB Q2 2026 results, 8-K Ex. 99.1 (2026-07-29) — https://www.sec.gov/Archives/edgar/data/0000060714/000119312526323751/lxu-ex99_1.htm — accessed 2026-10-04
- LSB Q2 2026 Form 10-Q — https://www.sec.gov/Archives/edgar/data/0000060714/000119312526326147/lxu-20260630.htm — accessed 2026-10-04
- LSB FY2025 results, 8-K Ex. 99.1 (2026-02-25) — https://www.sec.gov/Archives/edgar/data/60714/000119312526071665/lxu-ex99_1.htm — accessed 2026-10-04
- LSB FY2025 Form 10-K — https://www.sec.gov/Archives/edgar/data/60714/000119312526076810/lxu-20251231.htm — accessed 2026-10-04
- LSB FY2024 / FY2023 / FY2022 results, 8-K Ex. 99.1 — https://www.sec.gov/Archives/edgar/data/60714/000095017025027825/lxu-ex99_1.htm · https://www.sec.gov/Archives/edgar/data/60714/000095017024025979/lxu-ex99_1.htm · https://www.sec.gov/Archives/edgar/data/60714/000095017023003774/lxu-ex99_1.htm — accessed 2026-10-04
- LXU Q2 2026 earnings-call summaries (capex guidance; search summary) — https://stocktaper.com/earningsCallSummary/LXU/2026/Q2 — accessed 2026-10-04
- Fertilizer Daily, Tampa ammonia $555 September 2026 — https://www.fertilizerdaily.com/20260910-tampa-ammonia-price-555-september-2026-fourth-monthly-decline/ — accessed 2026-10-04
- StockAnalysis statistics: LXU, CF, UAN, NTR (2026-10-02 close) — https://stockanalysis.com/stocks/lxu/statistics/ — accessed 2026-10-04
- logs/macro-2026-10.md (10Y 5.28%, Brent ~$99.7, 2026-10-02)